STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
16.87
+0.02 (0.12%)
At close: Feb 21, 2025, 4:00 PM
16.80
-0.07 (-0.41%)
After-hours: Feb 21, 2025, 5:45 PM EST
STAAR Surgical Company Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for STAAR Surgical Company stock have an average target of 38.83, with a low estimate of 16 and a high estimate of 55. The average target predicts an increase of 130.17% from the current stock price of 16.87.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for STAAR Surgical Company stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $40 → $16 | Hold | Maintains | $40 → $16 | -5.16% | Feb 12, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 12, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 12, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 7, 2025 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $31 → $28 | Hold | Maintains | $31 → $28 | +65.98% | Dec 9, 2024 |
Financial Forecast
Revenue This Year
385.57M
from 313.90M
Increased by 22.83%
Revenue Next Year
437.26M
from 385.57M
Increased by 13.41%
EPS This Year
0.13
from -0.41
EPS Next Year
0.50
from 0.13
Increased by 279.12%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 427.4M | 500.9M | 590.1M | ||
| Avg | 385.6M | 437.3M | 548.4M | ||
| Low | 356.7M | 395.0M | 510.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.1% | 29.9% | 35.0% | ||
| Avg | 22.8% | 13.4% | 25.4% | ||
| Low | 13.6% | 2.5% | 16.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.91 | 1.13 | 0.92 | |
| Avg | 0.13 | 0.50 | 0.35 | |
| Low | -1.02 | -0.57 | -0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 755.2% | 83.8% | |
| Avg | - | 279.1% | -31.0% | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.